GENEVA, Feb. 11 -- ACAI THERAPEUTICS (160 Bovet RdSan Mateo, California 94402) filed a patent application (PCT/US2025/039784) for "CYP11A1 INHIBITOR COMPOUNDS AND USES THEREOF" on Jul 30, 2025. With publication no. WO/2026/030401, the details related to the patent application was published on Feb 05, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): XU, Lianhong (970 Blair CourtPalo Alto, California 94303)
Abstract: There are provided therapeutically active CYP11A1 inhibitor compounds of Formula (I) and pharmaceutical compositions thereof that are useful in the treatment of steroid receptor-d...